SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Riverlightning who wrote (688)7/7/1999 9:18:00 PM
From: Street Walker  Read Replies (1) of 5582
 
>>Dang, I want that $20 per share SOON.<<

We all do! I think we'll get there SOONER than later.
messages.yahoo.com

GUMM made a significant move last Friday on no news.
I would see that its normal for some investors to have
taken profits since it sat at 9 7/8 for so long. What is important, technically, is that GUMM shares were bought up on the dip which is bullish, imo. Something is up. This type of activity is typical before an annoucement.

Because of the very small trading float, GUMM price can be volatile
either way. The day will come when buyers will keep coming in day after day and the stock being sold will dry up whle the demand to buy shares increases, so the price will be pushed and pushed up until someone
decides to sell.

Here is a thought: the clinicals are nearly complete. Is is possible
there has been some "leaks" among friends of the clinicians, nurses,
and secretaries of the University clinics conducting the study?
I don't know any of the individuals so I am not attributing this to any specific person, but I do know that information from medical research has its way of leaking out and demonstrates itself in the share price.

S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext